Evidence map›Paper›PMID 35041709›Full record

ArticlePLoS pathogens2022

A Two-tiered functional screen identifies herpesviral transcriptional modifiers and their essential domains.

David W Morgens, Divya Nandakumar, Allison L Didychuk, Kevin J Yang, Britt A Glaunsinger

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

David W MorgensDepartment of Plant and Microbial Biology, UC Berkeley, Berkeley, California, United States of America.
Divya NandakumarDepartment of Plant and Microbial Biology, UC Berkeley, Berkeley, California, United States of America.
Allison L DidychukDepartment of Plant and Microbial Biology, UC Berkeley, Berkeley, California, United States of America.ORCID 0000-0001-7277-5233
Kevin J YangDepartment of Molecular and Cell Biology, UC Berkeley, Berkeley, California, United States of America.
Britt A GlaunsingerDepartment of Plant and Microbial Biology, UC Berkeley, Berkeley, California, United States of America.ORCID 0000-0003-0479-9377
University of California, Berkeley · USHoward Hughes Medical Institute · US

Funding

Regulation of Gammaherpesviral Late Gene ExpressionR01AI122528 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI Britt A Glaunsinger · 2016 to 2026
$4.2M
Pacific Biosciences PacBio RS Single Molecule Real Time SequencerS10OD018174 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI ROKHSAR, DANIEL SOLEYMAN · 2014 to 2014
$600k
NIAID NIH HHS R01 AI122528NIH HHS S10 OD018174
6 · The paper itself

Abstract

While traditional methods for studying large DNA viruses allow the creation of individual mutants, CRISPR/Cas9 can be used to rapidly create thousands of mutant dsDNA viruses in parallel, enabling the pooled screening of entire viral genomes. Here, we applied this approach to Kaposi's sarcoma-associated herpesvirus (KSHV) by designing a sgRNA library containing all possible ~22,000 guides targeting the 154 kilobase viral genome, corresponding to one cut site approximately every 8 base pairs. We used the library to profile viral sequences involved in transcriptional activation of late genes, whose regulation involves several well characterized features including dependence on viral DNA replication and a known set of viral transcriptional activators. Upon phenotyping all possible Cas9-targeted viruses for transcription of KSHV late genes we recovered these established regulators and identified a new required factor (ORF46), highlighting the utility of the screening pipeline. By performing targeted deep sequencing of the viral genome to distinguish between knock-out and in-frame alleles created by Cas9, we identify the DNA binding but not catalytic domain of ORF46 to be required for viral DNA replication and thus late gene expression. Our pooled Cas9 tiling screen followed by targeted deep viral sequencing represents a two-tiered screening paradigm that may be widely applicable to dsDNA viruses.

Indexed as

CRISPR-Cas SystemsGene Expression Regulation, ViralGenes, ViralHEK293 CellsHerpesvirus 8, HumanHumans

Identifiers

PMID35041709
PMCPMC8797222
OpenAlexW4226119321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.